Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.
COVID-19
Mortality
ST-segment elevation myocardial infarction
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
12
07
2022
received:
31
05
2022
accepted:
14
07
2022
pubmed:
20
7
2022
medline:
15
9
2022
entrez:
19
7
2022
Statut:
ppublish
Résumé
To compare major cardiovascular and cerebrovascular events (MACCE) rates between patients in the pre-COVID-19 era and COVID-19 era, and to assess the impact of the presence of COVID-19 (+) on long-term MACCE in ST-segment elevation myocardial infarction (STEMI) in Turkey. Using the TURSER study (TURKISH ST-segment elevation myocardial infarction registry) data, the current study included 1748 STEMI patients from 15 centres in Turkey. Patients were stratified into COVID-19 era (March 11st-May 15st, 2020; n = 723) or pre-COVID-19 era (March 11st-May 15st, 2019; n = 1025) cohorts. Long-term MACCE rates were compared between groups. In addition, the effect of COVID-19 positivity on long-term outcomes was evaluated. The primary outcome was the occurrence of MACCE at long-term follow-up, and the secondary outcome was hospitalization with heart failure. The MACCE and hospitalization with heart failure rates between pre-COVID-19 era and COVID-19 era were 23% versus 22% (p = .841), and 12% versus 8% (p = .002), respectively. In the COVID-19 era, the rates of MACCE and hospitalization with heart failure COVID-19-positive versus COVID-19-negative patients were 40% versus 20%, (p < .001), and 43% versus 11% (p < .001), respectively. There was no difference between the pre-COVID-19 era and the COVID-19 era in terms of MACCE in STEMI patients in Turkey. In the COVID-19 era, STEMI patients positive for COVID-19 had a higher rate of MACCE and heart failure hospitalization at the long-term follow-up.
Identifiants
pubmed: 35851657
doi: 10.1111/eci.13834
pmc: PMC9349930
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13834Informations de copyright
© 2022 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart. 2021;107:482-487.
Han Y. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience. Eur Heart J. 2020;41:2148-2149.
Choudry FA, Hamshere SM, Rathod KS, et al. High thrombus burden in patients with COVID-19 presenting with ST-elevation myocardial infarction. J Am Coll Cardiol. 2020;76(10):1168-1176.
Kiris T, Avci E, Ekin T, et al. Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry). J Thromb Thrombolysis. 2022;53(2):321-3345.
Phua K, Chew NWS, Sim V, et al. One-year outcomes of patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic. J Thromb Thrombolysis. 2022;53(2):335-345.
Rattka M, Stuhler L, Winsauer C, et al. Outcomes of patients with ST-segment elevation myocardial infarction admitted during COVID-19 pandemic lockdown in germany - Results of a single center prospective cohort study. Front Cardiovasc Med. 2021;8:638954.
Hartikainen TS, Sörensen NA, Haller PM, et al. Clinical application of the 4th universal definition of myocardial infarction. Eur Heart J. 2020;41(23):2209-2216.
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177.
Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22:6B-14B.
Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103:2550-2554.
Patel A, Jernigan DB, 2019-to CDC response team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United states, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-146.
Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America Expert consensus statement on reporting chest CT findings related toCOVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging. 2020;35(4):219-227.
Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871-2872.
Abdelaziz HK, Abdelrahman A, Nabi A, et al. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J. 2020;226:45-48.
Xiang D, Xiang X, Zhang W, et al. Management and outcomes of patients with STEMI during the COVID-19 pandemic in China. J Am Coll Cardiol. 2020;76(11):1318-1324.
Fileti L, Vecchio S, Moretti C, et al. Impact of the COVID- 19 pandemic on invasive coronary procedures at two Italian high-volume referral centers. J Cardiovasc Med. 2020;21(11):869-873.
Tomasoni D, Adamo M, Italia L, et al. Impact of COVID- 2019 outbreak on prevalence, clinical presentation, and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21(11):874-881.
Choudry FA, Rathod KS, Baumbach A, Mathur A, Jones DA. Long-term outcomes of COVID-19 associated ST-elevation myocardial infarction treated with primary PCI. Cardiovasc Revasc Med. 2022;25:S1553-S8389.
Çınar T, Şaylık F, Akbulut T, et al. One-year outcomes of invasively managed acute coronary syndrome patients with COVID-19. Heart Lung. 2022;52:159-164.
Lala A, Johnson KW, Januzzi JL. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533-546.